Log In
Print
BCIQ
Print
Print this Print this
 

CAM-1

  Manage Alerts
Collapse Summary General Information
Company Galapagos N.V.
DescriptionDNA polymerase III alpha inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat bacterial infection, including all drug-resistant forms of Staphylococcus aureus
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today